29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CMR quantification of infarct tissue heterogeneity and remote myocardial fibrotic burden during convalescent phase following acute myocardial infarction (MI) provided strong and complementary evidence of ventricular arrhythmogenicity from quantitative microvolt T-wave alternans testing (the NHLBI PROSPECT-CMR study)

      abstract

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary In patients with recent MI, elevated fibrotic burden within the remote myocardium quantified by CMR is strongly associated with post-exercise heart rate variability (HRV) and QT dispersion (QTD). In contrast, infarct tissue heterogeneity demonstrated strong association with prolonged mean QRS duration at rest and during exercise. We postulate that these patterns of ischemic structural/arrhythmogenic affiliations during convalescent infarct healing, likely reflect differences in depolarization/repolarization characteristics of different post-ischemic myocardium and sympathetic innervation. Background Risk of sudden cardiac death (SCD) is highest during the first 6 months following acute MI. Infarct tissue heterogeneity characterized by CMR has been shown to be associated with arrhythmogenic substrates and SCD. In the remote myocardium, it is unclear whether development of increased fibrotic content as a result of ventricular remodeling is of arrhythmogenic significance. We tested the hypothesis that myocardial status after an ischemic event had specific patterns of arrhythmogenicity. Methods We studied 85 patients (65 males) with CMR serially at 2-4 weeks and 6-months post-MI. During each visit we performed microvolt T-wave alternans (MTWA) testing using high resolution, ultra-sensitive electrodes. We assessed for arrhythmogenic markers including MTWA presence, QT dispersion (QTD), JT dispersion (JTD), mean QRS duration, and heart-rate variability (HRV). Post-processing of these markers was stratified to stages of exercise (rest, exercise, and post-exercise recovery). Total LGE size defined infarct size (in grams) and was subdivided into infarct core (CORE) and peri-infarct zone (PIZ) by previously described method. Fibrotic burden of remote myocardium was quantified with serial R1 mapping between myocardium and blood pool, up to 30 minutes after contrast administration. Fibrotic burden (normalized to hematocrit) was expressed as mean segmental fibrotic index (FIMeanSeg) and total fibrotic burden (FITotal). Results The association of myocardial fibrotic burden and infarct tissue characteristics with arrhythmogenic markers are shown in Table 1. Table 1 Association of CMR characteristics with markers of arrhythmogenicity Association of fibrosis within remote myocardium with abnormal repolarization Baseline HRV (post-exercise) FIMeanSeg r=0.49 (p=0.03) FITotal r=0.68 (p<0.001) 6-months QT Dispersion (post-exercise) FIMeanSeg r=0.72 (p=0.0007) Association of infarct tissue characteristics with abnormal depolarization Baseline QRS duration (at rest) QRS duration (during exercise) Total Infarct (g) r=0.44 (p<0.001) r=0.35 (p=0.006) CORE (g) r=0.45 (p=0.0001) r=0.41 (p=0.0002) PIZ (g) r=0.37 (p=0.0008) r=0.35 (p=0.0002) Fibrotic burden at baseline and 6 months following MI were strongly correlated with HRV (post-exercise) and QTD (post-exercise), respectively. Infarct tissue heterogeneity at baseline was strongly associated with prolongation of mean QRS duration during both rest and exercise. Conclusions Myocardial fibrotic burden was strongly associated with markers of abnormal repolarization. On the other hand, infarct tissue characteristics demonstrated strong correlation with abnormal electromyocardial depolarization. These findings support the notion that characterizing infarct tissue heterogeneity and non-infarcted myocardial fibrotic content may provide complementary information in advancing the knowledge of SCD risk in ischemic heart disease. Funding National Heart Lung and Blood Institute, National Institutes of Health (RO1-HL091157). Dr. Heydari's salary is supported by the Alberta Heritage Foundation for Medical Research.

          Related collections

          Author and article information

          Conference
          J Cardiovasc Magn Reson
          Journal of Cardiovascular Magnetic Resonance
          BioMed Central
          1097-6647
          1532-429X
          2012
          1 February 2012
          : 14
          : Suppl 1
          : O18
          Affiliations
          [1 ]Brigham and Women's Hospital, Boston, MA, USA
          [2 ]Internal Medicine, North Texas VA Medical Center, Bonham, TX, USA
          [3 ]Cardiology, Massachusetts General Hospital, Boston, MA, USA
          [4 ]Cambridge Heart, Cambridge, MA, USA
          [5 ]Leiden University Medical Center, Leiden, Netherlands
          Article
          1532-429X-14-S1-O18
          10.1186/1532-429X-14-S1-O18
          3304897
          58299db5-9089-48b4-b2a0-47204008c7c5
          Copyright ©2012 Heydari et al; licensee BioMed Central Ltd.

          This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

          15th Annual SCMR Scientific Sessions
          Orlando, FL, USA
          2-5 February 2012
          History
          Categories
          Oral Presentation

          Cardiovascular Medicine
          Cardiovascular Medicine

          Comments

          Comment on this article